Skip to main content
Clinical Trials/NCT06552130
NCT06552130
Active, not recruiting
Not Applicable

The Importance of Insulin Action in the Brain for the Immune System During Physical Activity

University of Ulm1 site in 1 country20 target enrollmentDecember 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insulin Sensitivity
Sponsor
University of Ulm
Enrollment
20
Locations
1
Primary Endpoint
Immune system activation
Status
Active, not recruiting
Last Updated
4 months ago

Overview

Brief Summary

The goal of this clinical trial is to clarify the interaction of central insulin action and physical activity with the immune system.

Therefore, participants will undergo bicycle spiroergometer tests. This approach will be compared between days with insulin delivery to the brain as nasal spray and days with placebo spray.

Detailed Description

This research project aims to investigate if the brain insulin action regulates the immune system via the autonomous nervous system during physical activity. Therefore, insulin action in the brain will be introduced by application of insulin as nasal spray (on one day) versus carrier solution as placebo nasal spray (on another day) in a randomized, blinded fashion. Spray administration will be performed 30 minutes before a 60 min bicycle spiroergometer test at 70 % VO2max that will introduce a postprandial state. On placebo day, the known spillover of tiny amounts of nasal insulin into the systemic circulation will be mimicked by an appropriate i.v. insulin bolus. Using this approach, brain-derived regulation of the immune system including the stimulation of immune cells via cytokines, physical performance, activity of the autonomous nervous system and gene-expression of leukocytes will be examined.

Registry
clinicaltrials.gov
Start Date
December 15, 2024
End Date
September 1, 2026
Last Updated
4 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University of Ulm
Responsible Party
Principal Investigator
Principal Investigator

Martin Heni

Head of the Section Endocrinology and Diabetology, Full Professorship (W3) for Endocrinology and Diabetology

University of Ulm

Eligibility Criteria

Inclusion Criteria

  • BMI \< 24 kg/m2
  • no known primary diseases
  • hormonal contraception with a single-phase preparation

Exclusion Criteria

  • Alcohol or drug abuse
  • At screening: Hb \< 12 g/dl for women and Hb \< 14 g/dl for men
  • Any (clinical) condition that would endanger participant's safety or question scientific success according to a physician's opinion.

Outcomes

Primary Outcomes

Immune system activation

Time Frame: 120 minutes

Influence of central nervous insulin action on the activation of the immune system activation by exercise, measured by the composition of immune cells in circulation and cytokine release in the supernatant of stimulated peripheral blood mononuclear cells.

Secondary Outcomes

  • Maximal oxygen consumption (VO2max)(60 minutes)
  • Heart rate variability(120 minutes)
  • Corticotropic pituitary axis modulation(120 minutes)
  • Leukocyte gene expression(120 minutes)
  • Individual anaerobic threshold(120 minutes)
  • Catecholamines(120 minutes)
  • Effects on blood coagulation parameters(120 Minutes)

Study Sites (1)

Loading locations...

Similar Trials